InnovAge (NASDAQ: INNV) reported Q3 EPS of ($0.22), $0.27 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $251.94 million versus the consensus estimate of $234.53 million.

GUIDANCE:

InnovAge sees FY2026 revenue of $950-975 million, versus the consensus of $952.3 million.

For earnings history and earnings-related data on InnovAge (INNV) click here.